NCT04215848View on ClinicalTrials.gov

As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

October 10, 2021

Study Completion Date

May 30, 2022

Conditions
Asthma
Interventions
DRUG

Budesonide/Formoterol Fumarate 160 MCG-4.5 MCG Inhalation Powder

After the patients who have all criteria, they will be randomized to take Budesonide/formoterol (160/4.5 μg/d) as need when they have symptoms.

DRUG

Budesonide 200Mcg Inhalation Powder

After the patients who have all criteria, they will be randomized to take Budesonide (200 μg) twice daily

Trial Locations (1)

90110

Hatyai Hospital, Hat Yai

All Listed Sponsors
lead

Hat Yai Medical Education Center

OTHER

NCT04215848 - As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period | Biotech Hunter | Biotech Hunter